Barry Sanders knows what it's like to leave the Lions with gas in the tank.
Good morning, everyone, and thank you for joining our fourth-quarter and full-year 2020 combined earnings conference call for NextEra Energy and NextEra Energy Partners. With me this morning are Jim Robo, chairman and chief executive officer of NextEra Energy; Rebecca Kujawa, executive vice president and chief financial officer of NextEra Energy; John Ketchum, president and chief executive officer of NextEra Energy Resources; and Mark Hickson, executive vice president of NextEra Energy, all of whom are also officers of NextEra Energy Partners; as well as Eric Silagy, president and chief executive officer of Florida Power & Light Company.
W. R. Berkley Corporation is not under any obligation and expressly disclaims any such obligation to update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. On the call, in addition to me, you also have Bill Berkley, Executive Chairman; as well as Rich Baio, Executive Vice President and Chief Financial Officer.
StrictionD Supplement Reviews: Does Rob Walker’s StrictionD supplement really help? Find out StrictionD supplement side effects, ingredients, benefits, gnc, price, customer experience and where to buy StrictionD Advanced Formula – StrictionD Reviews Updated [2021] by Nuvectramedical StrictionD Supplement Reviews: Does Rob Walker’s StrictionD supplement really help? Find out StrictionD supplement side effects, ingredients, benefits, gnc, price, customer experience and where to buy Chicago, IL, Jan. 26, 2021 (GLOBE NEWSWIRE) -- It's Time to Eradicate Diabetes Once and For All Diseases are very common and almost unavoidable as we all are humans and our system is used to getting repaired and then getting back to being healthy once again. This is like a cycle that we all are aware of. But there is this one disease that can take control of your body and curb your health and happiness together. It is none other than diabetes. As soon as reading this name some people must have already felt related to this situation. >> Click to visit the StrictionD Supplement Official Website Diabetes can leave you with no other options than to restrict yourself and live your life inside a box. Being a diabetic is more like being a prisoner who doesn't know when he will be set free. People wrongly fix their minds to prohibit the intake of a healthy diet from their routine life considering it to be boring. They feel lazy to prepare and eat healthy food. Do you know how people are damaging their health by eating chemically processed foods, junk foods and toxic foods? These foods are collapsing with the functions of all the organs and making them feel sick, providing additional side effects and finally pushing them towards the edge of life. Day by day the worst illnesses show up and make it difficult for you to live a healthy normal life. Why should you give a chance to that? Just make a few simple changes in your regular life and fix your routine by having the necessary nutrients, vitamins, minerals and other components in it. Now you are here to read this review thoroughly to know about one of the leading silent killer issues and how it can be controlled using this proven solution StrictionD within a few days. What Do You Know About StrictionD? Blood sugar plays a significant role in affecting your overall health. Rob Walker and team introduces the clinically proven dietary supplement StrictionD to help people who are suffering from blood sugar and related health issues. StrictionD is a dietary supplement that includes a few groundbreaking ingredients to take control of the blood sugar level and there won't be any need to use other harmful drugs henceforth in your life. The effect of using a StrictionD supplement will maximize the function of the pancreas for having better insulin secretion and for balancing the blood glucose level in your body rapidly. StrictionD is the right time to protect your body from some of the worst health conditions that might complicate your health. You can experience a faster result by making some changes in your diet plan and do some simple exercises to extend your lifespan. You can quickly identify the root cause of diabetes and fix it back by using three simple tricks, including a well-known superfood. >> Click to Know More About StrictionD Supplement How Does It Work For Everyone? Take control of your increased blood sugar using the StrictionD that is more effective when compared to other dietary supplements because it includes all the clinically proven natural ingredients with active components. By choosing this product; you will get the great offer of 3 proven tricks to keep your blood sugar level under a balance naturally. StrictionD boosts the insulin sensitivity, reduces or controls the blood sugar level, maintains cholesterol level and reduces the risk of heart disease simultaneously. StrictionD works effectively to avoid the painful complications and diseases which are linked with blood sugar, like blood pressure, obesity, vision loss, kidney failure, memory loss, cancer and more. StrictionD supplement recommends you to use three simple reversing tricks to treat the symptoms and the underlying cause of diabetes by making some changes in the food intake. StrictionD supplement includes a very special and specific form of Ceylon Cinnamon to remove the toxic content from the pancreas and liver and to lower the blood sugar level and balance it in the right way and also to improve cardiovascular health. While using this product, StrictionD suggests you to avoid cooking or making a salad dressing using cottonseed oil or corn oil or soybean oil. Because these oils contain more omega-6s that leads to insulin resistance, inflammation and diabetes. StrictionD also suggests you avoid all the packaged and processed food. Eating a healthy combination of food for your diet in a certain limit will allow you to keep the blood sugar under control by boosting the blood glucose metabolism rapidly. What Will You Get From This Dietary Product? Ceylon Cinnamon: It acts as a powerful superfood with unique bioactive properties to quickly boost insulin sensitivity, reduce or control blood sugar level and decrease cholesterol level. It contains Type A Polyphenols to boost insulin sensitivity which allows your body cells to absorb and use the glucose by blocking enzymes called tyrosine phosphatase, which induces insulin incompatibility. GlucoHelp: It is a high standard and natural extract of banana leaf originating in Southeast Asia, and is being used as a medicinal plant to lower the fasting glucose and post-prandial blood-glucose levels rapidly. It almost reduces blood glucose by up to 30% in just two weeks. Chrominex 3+: It is the most effective form of chromium that relieves arthritis pain and inflammation from your body thoroughly. It honestly supports you to have a healthy endothelial function and cholesterol level while boosting insulin sensitivity. With the effect of adding this special superfood and two powerhouse nutrients, you can quickly control the blood sugar level naturally and experience the desired result in overall health. StrictionD will deliver the best nutritional support to your body to heal the damaged pancreas and liver. StrictionD also boosts blood glucose metabolism to reverse diabetes and blood sugar overnight. Watch Now by Clicking Here: Critical Report About This Supplement Released! What Do You Get from Using StrictionD? StrictionD supplement is entirely natural and thus you do not have to worry about getting affected by various side effects. Be it high diabetes, pre-diabetes or if you are in a family of huge diabetes history, this supplement can make sure that you are no longer going to be a victim of diabetes. Unlike other supplements, StrictionD makes use of a very simply available natural ingredient named cinnamon to lower your blood sugar and thus keeps you healthy in the long run. Pros: StrictionD No longer be a silent sufferer of diabetes. Regulates your blood pressure. Reduces both your systolic and diastolic pressure. Treats type 2 diabetes effectively. 100% natural and thus no side effects. Provides great antioxidant support. Some of the downsides are, Cons: StrictionD You can purchase this supplement only on its official website.The results may vary for individuals. Before taking any supplement, you need to consult your doctor. Who should not use StrictionD? If you are under 18 or pregnant, you better avoid taking dietary supplements generally! It is always a good idea to consult your doctor before taking any supplement. FDA and Supplements: The FDA will never approve a dietary supplement. According to the Food and Drug Administration, dietary supplements are a category of their own, and they are not subject to FDA regulation or approval. If a company is claiming that the FDA approves their diet supplement, run. This is a clear misrepresentation. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Conclusion Getting rid of diabetes can be a very difficult task. But not anymore. StrictionD is here to treat your diabetes and maintain your blood sugar and ensure that it never exceeds the healthy level. StrictionD can be helpful for both men and women who are either diabetic or pre-diabetic. No more going behind those utterly useless prescribed medicines that are of no use. Get this StrictionD supplement now and say goodbye to diabetes forever and that too naturally. (HUGE SAVINGS TODAY) Click Here to Buy StrictionD Supplement for The Lowest Price Online Media Contact: US Address: 1608 S. Ashland Ave. Suite 73005 Chicago, IL. 60608 USA Email Us at Support@Optimal-Health.com Telephone: 1-844-248-3717 This product review is for informational purposes only. The information does not constitute advice or an offer to buy. Any purchase made from this story is made at your own risk. Consult an expert advisor/health professional before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website selling the product. The content on this release does not take any responsibility directly or indirectly. Contact Nuvectramedical at vijai@nuvectramedical.com This news has been published for the above source. Nuvectramedical [ID=16665] KISS PR PRODUCT REVIEWER COMPENSATION DISCLOSURE Pursuant to the Federal Trade Commission's guidance of the public in conducting its affairs in conformity with legal requirements comprised in 16 C.F.R. § 255 et seq. on the use of endorsements and testimonials in advertising, this Product Reviewer Compensation Disclosure is provided by KissPR.com LLC and its affiliated entities (hereinafter referred to collectively as “KISS PR”). This disclosure applies to content displayed on all mobile, desktop, and other online versions of KISS PR’s websites and to those of KISS PR’s distribution partners (hereinafter referred to collectively as “the Websites”) and is provided for the purpose of disclosing the nature of the connection between KISS PR and product reviewers, advertisers, sponsors, endorsers, and other third-parties whose advertisements, sponsorships, endorsements, testimonials, opinions, or other product-related or service-related statements or reviews may appear on the Websites (hereinafter referred to as an "Product Reviewer"). This Product Reviewer Compensation Disclosure is intended to disclose to you that in consideration of payment of monetary and other compensation from a Product Reviewer, as described below, KISS PR sells various advertising, sponsorships, and marketing campaigns that are featured on one or more of the Websites. There is a financial connection related to some of the products or services mentioned, reviewed, or recommended on the Websites between KISS PR and the Product Reviewer that owns, markets, or sells such product or service. If you decide to purchase a product or service featured on one or more of the Websites, KISS PR will not receive compensation related to that purchase from a Product Reviewer but may receive a one-time fee from the Product Reviewer for posting or distributing the product review on or via the Websites. Further, KISS PR may post or otherwise promote on the Websites content, including editorial content, which may feature third-party products and services (a "Reviewed Product"). This content may contain weblinks to third-party owned or operated web sites where you can purchase Reviewed Product (“Product Link”). If you click on a Product Link and then purchase a Reviewed Product on the linked web site, KISS PR will not receive compensation from the third-party offering the Reviewed Product (the “Vendor”). Weblinks on the Websites featuring a Reviewed Product may be added to posts or articles that are not identified on the Websites as comprising or containing paid or sponsored content. In such case, a disclosure statement about the Reviewed Product and the compensation that KISS PR might receive in connection with its purchase by you will be included in such posts or articles. Further, third-party advertisements may be posted on the Websites. Each time you click on such an advertisement, KISS PR may receive compensation from the third-party advertiser, even if you do not purchase any product or service from that third-party. KISS PR will, subject to the disclaimer of liability set forth below, endeavor to ensure that product or service endorsements appearing in the Websites or in posts or articles distributed via the Websites reflect the honest opinions, findings, beliefs, or experiences of the Product Reviewer as they relate to such product or service. If you have any complaint, concern, or question relating to the content of any such post or article, including alleged infringement of any intellectual property rights, you should address your complaint, concern, or question directly to the Product Reviewer or the Vendor. NO REPRESENTATIONS OR WARRANTIES; NON-RELIANCE. EXCEPT FOR ANY EXPRESS REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS DISCLOSURE STATEMENT, NEITHER KISS PR NOR ANY OTHER PERSON ON KISS PR’S BEHALF HAS MADE OR MAKES ANY EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY, EITHER ORAL OR WRITTEN, WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE, TRADE, OR OTHERWISE, ALL OF WHICH ARE EXPRESSLY DISCLAIMED, AND YOU ACKNOWLEDGE THAT YOU HAVE NOT RELIED UPON ANY REPRESENTATION OR WARRANTY MADE BY KISS PR OR ANY OTHER PERSON ON KISS PR’S BEHALF, EXCEPT AS SPECIFICALLY PROVIDED IN THIS DISCLOSURE STATEMENT. DISCLAIMER OF LIABILITY. IN NO EVENT SHALL KISS PR BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OF OR THE ACCURACY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY ADVERTISEMENT, SPONSORSHIP, ENDORSEMENT, TESTIMONIAL, OPINION, OR OTHER PRODUCT-RELATED OR SERVICE-RELATED STATEMENT OR REVIEW APPEARING IN THE WEBSITES OR IN ANY POST OR ARTICLE DISTRIBUTED VIA THE WEBSITES. © 2021 KissPR.com LLC Media Contact Website: [KISS PR Brand Story PressWire] - Email: Media@kisspr.com Attachment StrictionD Advanced Formula – StrictionD Reviews Updated [2021] by Nuvectramedical
Tradeweb Markets Inc. (Nasdaq:TW), a leading, global operator of electronic marketplaces for rates, credit, equities and money markets, today announced the appointment of James Sun as Managing Director, Head of Asia.
Toyoda Gosei Co., Ltd. proposes to merge its two group companies in India, Toyoda Gosei Minda India Pvt. Ltd. (TGMIN) and Minda TG Rubber Pvt. Ltd. (MTG), to improve management efficiency in the Indian market, an area of focus in Toyoda Gosei’s medium-term 2025 Business Plan.
TransEnterix, Inc. (NYSE American: TRXC) ("TransEnterix" or the "Company"), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 23,083,333 shares of common stock of the Company at a public offering price of $3.00 per share, less underwriting discounts and commissions. The Company also has granted the underwriter a 30-day option to purchase up to an additional 3,462,499 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about January 29, 2021, subject to customary closing conditions.
Good news about the easing of coronavirus restrictions was overshadowed by an awkward refusal of the NSW premier to answer one question.
BRISBANE, Australia, Jan. 27, 2021 (GLOBE NEWSWIRE) -- DECEMBER QUARTER 2020 KEY HIGHLIGHTS1 Olaroz Lithium Facility (Olaroz) operations returned to being Gross Cash Margin positive with record sales volume during the quarter while costs declined to near all-time lows. Quarterly production volumes were the third highest since operations commenced. Low costs and strong, stable production mean the business is well positioned to participate in the improving lithium market. Operations continued under the established Bio-Security Protocol with limits on the number of personnel on site for both production and expansion works. OLAROZ LITHIUM FACILITY (ORE 66.5%)2 Activities continue to focus on the health and well-being of our staff, contractors and communities while maintaining production and expansion worksOlaroz operations stopped for two days during October while successfully responding to a COVID-19 outbreak amongst 35 employeesProduction of 3,727 tonnes was up 58% quarter on quarter (QoQ), responding to increased demand and reflecting on-going plant stability and improved operating practicesSales volume was up 28% QoQ to a new record of 4,345 tonnes, while sales revenue was up 57% QoQ to US$16.5 million. The realised average price achieved was US$3,797/tonne on a free on board basis (FOB)3, up 22% QoQ. Sales volumes were 34% battery grade lithium carbonate and the remainder primary grade lithium carbonateCash costs (on a cost of goods sold basis)4 were US$3,623/tonne, down 9% QoQ excluding the export tax of US$85/tonne. All additional costs incurred as a result of COVID-19 restrictions and US$360,000 of non-recurring COVID-19 related wage subsidies from the Argentina government are included. Excluding the subsidies, the cost of sales remains the lowest level for more than three yearsGross cash margin was positive at US$174/t, an improvement of US$1,046/t on the September quarter with better pricing and lower costsFollowing the signature of an MOU in September, discussions with Prime Planet Energy and Solutions (PPES), an automotive battery cell manufacturing joint venture between Toyota (51%) and Panasonic (49%) are continuing for the supply of 30,000 tonne per annum (ktpa) of lithium carbonate equivalent (LCE) by CY25Lithium prices and volumes continue to recover and realised H2 FY21 prices are expected to increase >50% to approximately US$5,500/tonne (FOB) LITHIUM GROWTH PROJECTS Construction work on Stage 2 continued to be impacted during the quarter by COVID-19 restrictions. Construction has progressed to approximately 50% completion. Additional accommodation has been constructed for expansion personnel so that appropriate social distancing can be maintained as the workforce increases throughout 2021. Following a further review, Stage 2 is expected to commence production in H2 CY22, ramping up over two years to full capacity of 25,000 tonnes per annum of primary grade lithium carbonate by H2 CY24Naraha Lithium Hydroxide Plant construction has continued throughout the period with activities now approximately 89% completeA scoping study into a further expansion at Olaroz (Stage 3) will commence during the March quarter. The study will investigate options for additional production of 25-50ktpa from Olaroz, Cauchari or a combination of both, leveraging existing Stage 2 and 3 infrastructureInitial discussions have taken place with Toyota Tsusho Corporation (TTC) regarding an expansion of lithium hydroxide production as Naraha Stage 1 will be fully contracted based on ongoing negotiations with potential customers BORAX ARGENTINA Overall sales volume for the December quarter was 10,573 tonnes, up 18% QoQ and up 23% on the previous corresponding period (PCP)Sales revenue was up 14% QoQ due to increased volume, however the average price received was down 3% QoQ due to the sales mix CORPORATE During the quarter Orocobre completed a Share Purchase Plan (SPP) which raised funds of US$30.3 million following a placement in the September quarter. Total funds raised were approximately A$169 million before feesAs at 31 December 2020, Orocobre corporate had available cash of ~US$246.8 million of which US$11.1 million and US$59.6 million have been set aside as pre-completion guarantees for the Naraha debt facility and Olaroz Expansion debt facility respectivelyIncluding SDJ, Borax and Naraha cash and project debt, net group cash at 31 December 2020 was US$119.8 million, up from US$102.6 million at 30 September 2020 OLAROZ LITHIUM FACILITY Click here for more information on Olaroz COVID-19 As announced to the ASX on 26 October, COVID-19 infection was identified for the first time at our operations in 35 employees. In accordance with the Bio-Security Protocol, isolation procedures and contract tracing were conducted. Affected staff were relocated to Jujuy for medical treatment as required and have since recovered and returned to work. Operations were suspended for two days to allow cleaning and rotation of staff. Daily monitoring of workforce health continues throughout 14-21 day rosters that apply to all personnel and include those employees who would normally reside in local communities. Since July 2020, the Company medical service has performed more than 5,200 COVID-19 tests (Serological and PCR). SAFETY Health and safety remains a key priority for the Company. No Lost Time Injuries (LTI) were recorded at Olaroz during the first two quarters of FY21. As at 31st December the operations recorded 342 days without an LTI. The Intelex database for HSE and Quality events management was officially launched during the December quarter. At this stage the system is used extensively by mid-line supervisors and managers. Intelex serves as an event management system following a workflow that allows the team to report, check, classify, investigate, develop corrective and preventive action plans. During the remainder of the year Olaroz will complete the transition from the current system (SMC) to Intelex. Lagging and key leading indicators have been defined to measure and improve safety and environmental performance and are now tracked through the Intelex database. The Dupont programs continue to enhance our safety culture and remain a key priority even during the current COVID-19 situation. OPERATIONAL UPDATE QUALITY Plant stability and reliability remains very good with improved process capability (CpK). The process capability index or process capability ratio is a statistical measure of process capability which is the ability of a process to produce output within specification limits. Brine feed concentration to the plant also continues to improve year on year with December quarter concentrations over 8,000ppm reflecting some seasonal variation, additional pond capacity and strong underlying improvement in pond management practices. Product quality continues to improve with reduced magnetic particles and increased product consistency. PRODUCTION Production for the December quarter was third highest achieved by Olaroz at 3,727 tonnes up 4% from 3,586 tonnes in the PCP. Brine concentration remains at higher levels than in recent years resulting in high daily production rates, higher plant recovery and further decreases in costs, even when COVID-19 related costs are included. Production of battery grade lithium carbonate was 34% of total production, up from 22% in the September quarter. SALES AND COMMERCIAL Product sales were a record at 4,345 tonnes of lithium carbonate up 32% on PCP and 28% QoQ. The average price received was US$3,797/tonne on an FOB basis up 22% QoQ but down 29% PCP5 due to weaker pricing relative to a year ago. Some sales reflect contracts that were agreed in August, September and October reflecting lower prices that were current at the time. Contracts from later in the December quarter and into 2021 are being completed at higher prices. Total sales revenue was up 57% QoQ to US$16.5 million but down 6% PCP. Lithium prices and volumes continue to recover and realised H2 FY21 prices are expected to be up >50% to approximately US$5,500/tonne (FOB). PPES MOU During the September quarter Orocobre entered into a non-binding MOU with PPES, a joint venture between Toyota (51%) and Panasonic (49%) specialising in the production of automotive battery cells, for the long-term supply of product culminating in 30kt of LCE in CY25. Discussions are continuing to finalise this agreement. COSTS/MARGINS Cash cost of goods sold for the quarter (including COVID-19 related costs and US$360,000 of COVID-19 wage subsidies from the Argentina government) reduced by 15% PCP to near all-time lows at US$3,623/tonne. This excludes export duties for the quarter of US$85/tonne. Gross cash margins for the quarter returned to being positive at US$174/tonne, this is expected to improve with better pricing in H2 FY21. MetricDecquarter 2020Septquarter 2020Change QoQ (%)PCP(Dec qtr 2019)Change PCP (%)Production (tonnes)3727235258%3,5864%Sales (tonnes)4345339328%3,28732%Average price received (US$/tonne) 33797310222%5,335-29%Cost of sales (US$/tonne)436233974-9%4,266-15%Revenue (US$M)16.51157%18-6%Gross cash margin (US$/tonne)174-872120%1,069-84%Gross cash margin (%)5%-28%116%20%-77%Export tax (US$/tonne)857021%238-64% Total cost of sales has continued to decrease and is materially lower than the previous corresponding period demonstrating the significant focus and reduction of fixed costs within the operating business. STAGE 2 EXPANSION AT OLAROZ PROGRESS TO DATE Work during the December quarter has continued with a reduced workforce adhering to COVID-19 restrictions. As at 31 December, 2020 construction work has achieved approximately 50% completion. Key areas of development are brine extraction wells and gathering systems, lime plant, collection ponds and carbonation/soda ash plants. Capital expenditure to the end of the quarter is approximately US$172 million, excluding VAT and working capital. All of the steel structure for the carbonation and soda ash plants has now arrived at site including cladding, roofing and overhead cranes. The construction contract for the carbonation plant has been awarded and works are expected to commence in mid-February once the remaining terms of the contract are finalised. Expansion of the construction camp is well underway which will allow the workforce to grow as required by the current schedule. Original plans for expansion workforce accommodation envisaged two or more people per room, however with social distancing requirements limiting accommodation to one person per room additional rooms are now being installed. Following a further review and planning around COVID-19 restrictions, Stage 2 is expected to commence production in H2 CY22 and ramp up over two years to full capacity of 25ktpa of primary grade lithium carbonate by H2 CY24. NARAHA LITHIUM HYDROXIDE PLANT PROGRESS TO DATE The Naraha Plant, the first of its kind to be built in Japan, is designed to convert primary grade lithium carbonate feedstock into purified battery grade lithium hydroxide. Feedstock for the 10,000 tonne per annum (tpa) Naraha Plant will be sourced from the Olaroz Lithium Facility’s Stage 2 Expansion that will produce primary grade (>99.0% Li2CO3) lithium carbonate. Since construction commenced at the Naraha Plant there have been no LTIs recorded. As at 31 December, approximately US$50 million has been spent on engineering, civil works, electrical, instrumentation, fabrication and procurement at the Naraha Plant. Site operations have continued throughout the period with construction now approximately 89% complete, and commissioning expected in H2 CY21. FURTHER GROWTH PROJECTS Upon completion of PPES and other customer agreements in the next several months, both Olaroz Stage 2 and Naraha Stage 1 are expected to be fully contracted. In order to maintain the targeted 5-10% global market share beyond 2025, Orocobre is investigating additional production of both lithium carbonate and lithium hydroxide. Olaroz Stage 3 A scoping study into a further expansion at Olaroz (Stage 3) will commence during the March quarter. The study will investigate options for additional 25-50ktpa of lithium carbonate production. The study will consider technical, financial and commercial options for further production including from the 100% Orocobre owned Cauchari resource. Stage 3 at Olaroz will be a high value growth option that will benefit from capital and operating cost synergies with Stages 1 and 2. As a brownfield development it will have low technology and resource risk with a well understood processing route for the Olaroz/Cauchari brine. Access to key existing infrastructure such as the national highway, a dedicated gas pipeline and renewable energy will underpin financial and sustainability metrics and returns. Stage 3 is a unique growth option that will be well timed to meet growing demand for lithium based batteries. Naraha 2 Initial discussions with TTC have confirmed the intention to expand lithium hydroxide production. The next step will be to consider the potential scale of additional production and whether that is located at Naraha or another site that better suits customer needs, or provides scope for potential further stages as may be required to match growth by PPES and other customers. SHARED VALUE PROGRAM AND COMMUNITY The Shared Value team built on their knowledge of local communities and sustainability with a combination of remote work and a number of visits to communities that are directly and indirectly influenced by the company’s operations. Key actions during the quarter included: Community Relations Management of work rosters within COVID-19 limitations: Communication with Community Coordinators, local government contacts and local suppliers to manage and confirm the date and location of PCR sample collection (COVID-19 tests) and the transfer schedules for rostered employeesIdentification of risks and opportunities for the social development of communities within the COVID-19 environment. COVID-19 has presented new challenges for the optimal management of interaction and implementation of programs within local communitiesOngoing management of community relations and engagement with community members and leaders responding to any concerns and facilitating cooperationField work: visits were made to the communities of Susques, Huancar, Pastos Chicos, Coranzuli and Olaroz ChicoThe team participated in the first meeting for 2020 of the Council on Indigenous Participation. This Council brings together the ten communities of the People of Atacama. Discussions focused on local labour, prioritization of local suppliers at the Olaroz Lithium Facility and participation of local suppliers in the Olaroz Stage 2 Expansion Community development programs Program to Support Food Independence: Family Food Production Units UPAFA program to encourage independent food supply in local communities continued during the quarter. Support visits to four vegetable gardens in Coranzuli were conducted with a focus on production records, transplanting of seedlings and optimisation of irrigation. Materials for greenhouse enclosures, hand tools and spring/summer seeds were delivered to the communities of Huancar and Pastos Chicos. A training session on UPAF was held in Olaroz Chico. Sustainable Management of Vicuñas at Olaroz ChicoParticipants in the Vicuna management program at Olaroz Chico were supported in the development of a conservation and management plan. Family Farming program technicians from the National Institute of Technology (Jujuy) were provided training in the natural and cultural heritage of local communities. Community Investment Program Construction of community halls in Susques and El Toro were completed during the quarter. Planning and design is underway for a further community hall in Coranzuli with construction to commence in the first quarter of 2021. MARKET The lithium market continued on a path of recovery during the December quarter, confirming a bottom had been reached in the preceding months. The Chinese lithium carbonate market demonstrated particular strength with spot prices rising ~50% between September 2020 and December 2020 as domestic supply became increasingly tight as demand from the electric vehicle (EV) sector accelerated. DEMAND Underlying fundamentals for electric vehicles continue to improve with an increasing number of commitments to EVs by national governments such as those announced by the United Kingdom in late 2020 which will ban petrol and diesel vehicle sales by 2030. The success of government mandated EV initiatives can be seen in the Norwegian market with EVs accounting for ~80% of new car sales in October 2020. All new car sales in Norway are expected to be EVs by 2025. There are multiple other growth catalysts that are driving lithium demand including a change of government in the US and proposed US$2 trillion renewables stimulus, European carbon emissions penalties on automakers, and the growing range and affordability of popular EV brands in China. Chinese EV demand continued to outperform expectations with the leading industry body, the Chinese Association of Automobile Manufacturers (CAAM) revising the 2020 New Energy Vehicle (NEV) forecast from 1.1 million units mid-year to 1.3 million units outperforming 2018 and 2019 levels. December 2020 marked the sixth consecutive month of growth in NEV sales in China, with a high proportion of pure battery electric vehicles (BEV’s) at 70-80% versus plug-in hybrid (PHEV) resulting in higher lithium consumption with the larger battery size of a BEV relative to a PHEV. China’s demand for lithium carbonate remained higher than the rest-of-world due to a resurgence of LFP battery formats and continued use of mid nickel NMC cathodes by Chinese battery makers producing adequate range for the majority of China’s EV buyers. SUPPLY As Chinese brine producing regions became prohibitively cold, production declined and inventories were quickly reduced, limiting availability of industrial carbonate to upgrading converters as well as cathode manufacturers who seek to maximise the use of lower cost material. This supply dynamic throughout the quarter decreased the premium, battery grade carbonate typically achieves over industrial carbonate. Supply discipline by spodumene producers and earlier mine closures meant converter stock levels also declined. As a result, China’s demand for South American lithium chemical supply grew over the quarter absorbing increased supply from Chile which had previously played a large part in driving Chinese prices down. Continued tightening in the lithium market is expected during the March quarter as Chinese brine remains restricted by weather conditions and Chinese spodumene converter output is bound by feedstock availability. Rest of world supply increases will also be limited given most South American producers have delayed 2021 expansion plans to 2022 and greenfield projects have been pushed back by lack of funding and/or high cost of capital. BORAX ARGENTINA S.A. SAFETY Following a number of safety incidents earlier in the year, Borax has improved safety performance and the team have worked hard to restore the safety commitment and accountability at all levels of the operating business. A safety stand down was implemented at Campo Quijano which allowed the operating team to participate in an extensive safety workshop, which included a review of all critical activities. Additionally, a new Safety Manager and three new experienced supervisors were recruited. Subsequent to the safety stand down, there have not been any LTI or Environmental incidents at the three operational Borax sites during the December quarter. As at 31 December, Sijes recorded 184 days free of accidents, Tincalayu achieved 168 days and Campo Quijano has had 127 days LTI free. This quarter Borax was successfully recertified for ISO 9001 and 14001. A partnership was established with “Saltaplast” to implement circular economy initiatives with an initial focus on waste recycling. Safety initiatives for the second half of the year will include the development of a local emergency response team, improvement of the work permit safety system and planning\implementation of the February and March maintenance programs. PRODUCTION, SALES AND OPERATIONAL UPDATE The December quarter achieved sales of 10,573 tonnes, up 18% QoQ and approximately 23% up from the previous corresponding period. Total sales revenue was up 14% QoQ, while the average price received was down 3% QoQ due to the sales mix. Operations have continued under the Orocobre Bio-security Protocol and to date no cases of COVID-19 have been recorded at any Borax site. COMBINED PRODUCT SALES VOLUME BY QUARTER Previous Year Quarters Recent Quarters March 201913,0416 March 202010,690June 201911,758 June 202012,278September 201912,480 September 20208,964December 20198,614 December 202010,573 CORPORATE AND ADMINISTRATION FINANCE CASH BALANCE As at 31 December 2020, Orocobre corporate had available cash of ~US$246.8 million of which US$11.1 million and US$59.6 million have been set aside as pre-completion guarantees for the Naraha debt facility and Olaroz Expansion debt facility respectively. The US$21.5 million corporate cash increase from the previous quarter includes inflows of US$30.3 million from the Share Purchase Plan, US$2.4 million from proceeds of a mining property usufruct sale, and US$0.4 million of interest income partially offset by US$11.6 million of outflows. The outflows of cash were US$9.4 million advanced to SDJ Joint Venture (SDJ) as a shareholder loan to fund the cash shortfall of the business, US$1.4 million corporate costs and US$0.8 million to Borax. Including SDJ and Borax cash and project debt, net group cash at 31 December 2020 was US$119.8 million, up from US$102.6 million at 30 September 2020. ARGENTINA ECONOMIC CONDITIONS Currency: The official foreign exchange rate depreciated by 10.5% in the December quarter from AR$76.18 at 30 September 2020, to AR$84.15 at 31 December 2020. The accumulated 12-month period from 1 January 2020 to 31 December 2020 resulted in a 41% devaluation of the AR$ against the US$. Inflation: December’s inflation was 4% and accumulated 11.4% in the quarter. The accumulated 12-month period from 1 January to 31 December 2020 resulted in inflation of approximately 36%. Export duties: On 30 December 2020, the Argentine government passed a decree updating the levy on export duties to a fixed percentage of 4.5% which compares to the previous levy of ARS$3 per US$1 of export sales. The average export duty rate applicable to FY20 was 5%, however for the six- month period 1 July to 31 December 2020 it was 3.9% under the ARS$3 per US$1 levy calculation. Authorised by: Rick AnthonJoint Company Secretary FOR FURTHER INFORMATION PLEASE CONTACT: Andrew BarberChief Investor Relations OfficerOrocobre Limited P: +61 7 3720 9088M: +61 418 783 701 E: abarber@orocobre.comW: www.orocobre.comClick here to subscribe to the Orocobre e-Newsletter ______________________________________ 1 All figures presented in this report are unaudited2 All figures 100% Olaroz Project basis3 Orocobre report price as “FOB” (Free On Board) which excludes insurance and freight charges included in “CIF” (Cost, Insurance, Freight) pricing.Therefore, the Company’s reported prices are net of freight (shipping), insurance and sales commission. FOB prices are reported by the Company to provide clarity on the sales revenue that is recognized by SDJ, the joint venture company in Argentina4 Excludes royalties, export tax and corporate costs 5 December quarter 2019 Cost of Sales and Average Price Received have been updated to reflect adjustments made in FY20 Half Year results6 Includes 2,312 tonnes of low value mineral product
Premier Annastacia Palaszczuk sees Norfolk Island as an opportunity to build Queensland's tourism portfolio.
PORTLAND, Tenn., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (the “Company”) today announced the pricing of its upsized initial public offering of 77,000,000 shares of its Class A common stock at a price to the public of $25.00 per share. The offering consists of 9,000,000 shares of Class A common stock being sold by the Company and 68,000,000 shares of Class A common stock being sold by a parent entity of the Company controlled by funds managed by Oaktree Capital Management, L.P. (the “Selling Stockholder”). In addition, the Company and the Selling Stockholder granted the underwriters a 30-day option to purchase up to an additional 11,550,000 shares (the “Additional Shares”) at the public offering price, less underwriting discounts and commissions. The Additional Shares consist of up to 2,550,000 shares of Class A common stock offered by the Company and up to 9,000,000 shares of Class A common stock offered by the Selling Stockholder. The Company will not receive any proceeds from any sale of shares by the Selling Stockholder. The shares of Class A common stock are expected to begin trading on the Nasdaq Global Market on January 27, 2021 under the symbol “SHLS.” The offering is expected to close on January 29, 2021, subject to customary closing conditions. Goldman Sachs & Co. LLC and J.P. Morgan are acting as joint book-running managers and representatives of the underwriters for the offering. Guggenheim Securities and UBS Investment Bank are also acting as joint book-running managers and Morgan Stanley, Barclays and Credit Suisse are acting as book-runners. Cowen and Oppenheimer & Co. Inc. are acting as co-managers. A registration statement relating to this offering was declared effective by the Securities and Exchange Commission on January 26, 2021. This offering is being made only by means of a prospectus, copies of which may be obtained, when available, from: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282 (telephone: (866) 471-2526 or email: prospectus-ny@ny.email.gs.com); J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (telephone: 1-866-803-9204), or by email at prospectus-eq_fi@jpmchase.com; Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison, 8th Floor, New York, NY 10017, by telephone at (212) 518-9658, or by email at GSEquityProspectusDelivery@guggenheimpartners.com; and UBS Securities LLC, Attention: Prospectus Department, 1285 Avenue of the Americas, New York, NY 10019, by telephone at (888) 827-7275 or by email at ol-prospectus-request@ubs.com. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Shoals Technologies Group, Inc. Shoals Technologies Group, Inc. is a leading provider of electrical balance of systems (“EBOS”) solutions for solar, storage, and electric vehicle charging infrastructure. Since its founding in 1996, the Company has introduced innovative technologies and systems solutions that allow its customers to substantially increase installation efficiency and safety while improving system performance and reliability. Shoals Technologies Group, Inc. is a recognized leader in the renewable energy industry whose solutions are deployed on over 20 GW of solar systems globally. Forward Looking Statements This press release contains forward looking statements, including statements regarding the initial public offering. These statements are not historical facts but rather are based on the Company's current expectations and projections regarding its business, operations and other factors relating thereto. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates” and similar expressions are used to identify these forward looking statements. These statements are only predictions and as such are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Actual results may differ materially from those in the forward looking statements as a result of a number of factors, including those in the Company's registration statement filed with the Securities and Exchange Commission. Contacts: Phone: 615-323-9836 Investors:Email: investors@shoals.com Media:Email: media@shoals.com
A rise in child care and tobacco costs were key drivers in a rise in inflation in the December quarter, but the annual rate was still a benign 0.9 per cent.
Google is reviving plans to launch its own news website in Australia within weeks, according to a local media outlet contracted to provide articles for the venture, as the search giant fights world-first proposed laws on content payments. The launch of the News Showcase product as early as next month is Google's latest tactic in a high-profile campaign against the Australian government's planned legislation to make the company pay local news providers for content that appears in its search engine. Google had announced plans to launch News Showcase in Australia last June, signing deals with six small local outlets, including The Conversation, for content.
A teenager will remain in custody charged with murder after the allegedly stolen Landcruiser struck and killed two pedestrians in Brisbane.
MSCI's gauge of Asian ex-Japan shares slipped 0.3%, dragged lower by profit-taking in resource shares as some investors have grown wary of stretched valuations. Microsoft shares rose 4% in extended trading after its Azure cloud computing services grew more 50%.
SA is dealing with fruit fly outbreaks in various areas across Adelaide and the state's Riverland which is threatening the horticulture sector.
A Sanford C. Bernstein prognosticator believes the company can produce double-digit growth in its dedicated user base for many years.
CEDARHURST, N.Y., Jan. 26, 2021 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. Boston Scientific Corporation (BSX) Class Period: April 24, 2019 and November 16, 2020Lead Plaintiff Motion Deadline: February 2, 2021SECURITIES FRAUD To learn more, visit https://kclasslaw.com/cases/securities/nyse-bsx/ Splunk Inc. (SPLK) Class Period: October 21, 2020 and December 2, 2020Lead Plaintiff Motion Deadline: February 2, 2021SECURITIES FRAUD To learn more, visit https://kclasslaw.com/cases/securities/nasdaqgs-splk/ Shareholders who purchased shares in these companies during the dates listed are encouraged to contact us via the case links above, by calling toll-free at 1-833-835-1495 or by email (dk@kclasslaw.com). If you wish to serve as lead plaintiff with the goal of overseeing the litigation to obtain a fair and just resolution, you must petition the Court on or before the deadlines provided above. Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Kuznicki Law PLLCDaniel Kuznicki, Esq.445 Central Avenue, Suite 344Cedarhurst, NY 11516Email: dk@kclasslaw.comPhone: (347) 696-1134Cell: (347) 690-0692Fax: (347) 348-0967https://kclasslaw.com
As coronavirus lockdowns are extended across Europe, protests have flared in its hard-hit hospitality sector, along with warnings that many businesses are on the verge of extinction.
(Bloomberg) -- Asian stocks fluctuated Wednesday after their biggest slide in two months as investors mulled a slew of earnings reports amid worries over virus variants and hurdles to stimulus. Nasdaq futures climbed.Stocks pared earlier gains across much of the region. Australia underperformed as it reopened after a holiday. Nasdaq 100 contracts jumped following a strong earnings report from Microsoft Corp. S&P 500 futures fluctuated after the benchmark ended an up-and-down session slightly lower. Treasury yields were little changed and the dollar edged up.Microsoft said fiscal second-quarter sales rose faster than expected thanks to buoyant cloud demand, while Advanced Micro Devices Inc. gave an upbeat forecast, reflecting strong demand for its chips.Elsewhere, oil edged higher and gold slipped. Bitcoin dipped below the $32,000 level.Global stocks are mostly treading water near record highs as U.S. corporate earnings season gears up this week. New coronavirus variants that sparked fresh lockdowns and other restrictions are weighing on the so-called reflation trade that bets on an end to curbs. Investors are also seeking more clarity on the timeline for President Joe Biden’s $1.9 trillion Covid-19 relief plan.“For the reopening trade to really have persistence it is going to need to show a much broader participation across the market,” Jim McDonald, chief investment strategist at Northern Trust, said on Bloomberg TV. “The virus vaccine rollout is the most important development to help give confidence in the shape of the recovery.”Data showed global coronavirus cases surpassed 100 million. The U.K. became the first nation in Europe with 100,000 deaths. The Biden administration intends to order 100 million more doses each of Pfizer Inc. and Moderna Inc.’s coronavirus vaccines and at least temporarily speed up shipments to states.These are some key events coming up in the week ahead:Apple Inc., Tesla Inc., Facebook Inc. and Samsung Electronics Co. are among companies reporting results.The Federal Open Market Committee monetary policy decision and briefing by Chair Jerome Powell are scheduled for Wednesday.Fourth-quarter GDP, initial jobless claims and new home sales are among U.S. data releases Thursday.U.S. personal income, spending and pending home sales come Friday.These are the main moves in markets:StocksS&P 500 futures fell 0.1% as of 12:30 p.m. in Tokyo. The S&P 500 Index fell 0.2%.Topix index rose 0.4%.Australia’s S&P/ASX 200 Index fell 0.8%.Kospi index was little changed. Hong Kong’s Hang Seng Index rose 0.2%.Shanghai Composite Index was flat.Euro Stoxx 50 futures fell 0.2%.CurrenciesThe yen traded at 103.73 per dollar.The offshore yuan was at 6.4677 per dollar.The Bloomberg Dollar Spot Index rose 0.1%.The euro traded at $1.2158.The British pound was at $1.3734.BondsThe yield on 10-year Treasuries was at 1.04%.Australia’s 10-year bond yield fell two basis points to 1.09%.CommoditiesWest Texas Intermediate crude rose 0.4% to $52.84 per barrel.Gold dipped 0.2% to $1,847.40 an ounce.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Yahoo Finance